RediNews
ETFs Holding ABBV »    ABBV Historical Stock Prices »
ABBV News Video: Fri, Jul 28, 2017, 10:47 AM — USMV, FTXH: Big ETF Outflows


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. Self directed investors in AbbVie will be interested in keeping up with all AbbVie news they can find, both ABBV news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ABBV. At RediNews, we simplify this task by presenting both ABBV news releases originating from AbbVie itself, and ABBV news from a variety of media outlets. Visitors can browse this news online and through our ABBV RSS news feed.

AbbVie News

AbbVie News — Articles, Videos, & Press Releases

Gilead (GILD) NDA for HIV Combo Regimen Gets Priority Review
Monday, August 14, 2017, 7:44 AM — Zacks
IWF, ABBV, CELG, AVGO: Large Outflows Detected at ETF
Friday, August 11, 2017, 10:46 AM — ETF Channel
The New #166 Most Shorted S&P 500 Component: ONEOK
Thursday, August 10, 2017, 3:25 PM — Market News Video
AbbVie Inc a Top 25 Dividend Giant With 3.56% Yield (ABBV)
Thursday, August 10, 2017, 9:55 AM — ETF Channel
Infinity (INFI) Q2 Loss Wider than Expected, View Intact
Friday, August 4, 2017, 2:29 PM — Zacks
Momenta (MNTA) Q2 Loss In Line with Estimates, Sales Beat
Thursday, August 3, 2017, 3:04 PM — Zacks
Top Buys by Directors: Rapp's $281.8K Bet on ABBV
Thursday, August 3, 2017, 2:13 PM — Dividend Channel
Noteworthy ETF Outflows: VYM, PFE, MMM, ABBV
Tuesday, August 1, 2017, 11:53 AM — ETF Channel
Key FDA Events to Watch Out for in Aug 2017
Tuesday, August 1, 2017, 5:29 AM — Zacks
Drug Stocks Q2 Earnings Releases on Aug 1: PFE, AERI & INCY
Monday, July 31, 2017, 8:30 AM — Zacks
Notable Friday Option Activity: MA, ABBV, APA
Friday, July 28, 2017, 2:27 PM — Stock Options Channel
AbbVie (ABBV) Tops Q2 Earnings & Revenues, Outlook Intact
Friday, July 28, 2017, 1:20 PM — Zacks
AbbVie (ABBV) Tops Q2 Earnings and Revenue
Friday, July 28, 2017, 6:13 AM — Zacks
Friday's Earnings Reports To Watch: XOM, CVX, MRK, ABBV
Thursday, July 27, 2017, 2:34 PM — Zacks
Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK
Thursday, July 27, 2017, 8:42 AM — Zacks
Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales
Thursday, July 27, 2017, 6:59 AM — Zacks
Gilead (GILD) Tops Q2 Earnings& Revenue Estimates, Stock Up
Thursday, July 27, 2017, 6:00 AM — Zacks
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, July 26, 2017, 8:50 AM — ETF Channel
Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up
Tuesday, July 25, 2017, 12:37 PM — Zacks
Noteworthy ETF Inflows: VYM, PFE, MMM, ABBV
Monday, July 24, 2017, 10:53 AM — ETF Channel
Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs
Monday, July 24, 2017, 8:11 AM — Zacks
AbbVie Inc's. (ABBV) Q2 Earnings: Disappointment in Store?
Friday, July 21, 2017, 2:22 PM — Zacks
Is Gilead (GILD) Poised for a Beat This Earnings Season?
Thursday, July 20, 2017, 6:30 AM — Zacks
Gilead's HCV Portfolio Receives a Boost With Vosevi Approval
Wednesday, July 19, 2017, 8:15 AM — Zacks
Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?
Wednesday, July 19, 2017, 7:52 AM — Zacks
Perrigo Company Gets FDA Approval for Generic Topical Gel
Tuesday, July 18, 2017, 4:12 PM — Zacks
Repros' Proellex Stays on Partial Clinical Hold, Shares Fall
Tuesday, July 18, 2017, 3:50 PM — Zacks
Notable ETF Inflow Detected - VHT, PFE, MDT, ABBV
Friday, July 14, 2017, 10:52 AM — ETF Channel
J&J (JNJ) Gets FDA Nod for Psoriasis Drug -- Guselkumab
Friday, July 14, 2017, 8:22 AM — Zacks
Can Novartis (NVS) Spring a Surprise This Earnings Season?
Friday, July 14, 2017, 6:18 AM — Zacks
CME Group Becomes #137 Most Shorted S&P 500 Component, Replacing AbbVie
Thursday, July 13, 2017, 2:52 PM — Market News Video
Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label
Wednesday, July 12, 2017, 8:05 AM — Zacks
IPO Market Back On Track: ETFs to Tap
Wednesday, July 12, 2017, 7:50 AM — Zacks
Noteworthy Tuesday Option Activity: PH, YELP, ABBV
Tuesday, July 11, 2017, 3:36 PM — Stock Options Channel
Roche (RHHBY) Announces Positive Data on Hemophilia A Drug
Tuesday, July 11, 2017, 3:32 PM — Zacks
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Monday, July 10, 2017, 10:00 AM — Dividend Channel
Novartis' Cosentyx Superior to Stelara in Psoriasis Study
Monday, July 10, 2017, 9:12 AM — Zacks
Bristol-Myers Gets FDA Nod for Orencia's Label Expansion
Friday, July 7, 2017, 7:16 AM — Zacks
Galapagos-Gilead Begin Phase II Study on Uveitis Candidate
Wednesday, July 5, 2017, 2:57 PM — Zacks
Vanguard High Dividend Yield ETF Experiences Big Outflow
Wednesday, July 5, 2017, 10:52 AM — ETF Channel
Bayer Starts Phase III Study for Uterine Fibroids' Candidate
Tuesday, July 4, 2017, 6:25 AM — Zacks
Roche's (RHHBY) Leukemia Drug Gets Prime Status in EU
Friday, June 30, 2017, 8:07 AM — Zacks
Target Becomes #125 Most Shorted S&P 500 Component, Replacing AbbVie
Tuesday, June 27, 2017, 2:41 PM — Market News Video
Health Care Select Sector SPDR Fund Experiences Big Inflow
Tuesday, June 27, 2017, 11:44 AM — ETF Channel
Gilead's (GILD) HCV Drug Application Accepted in the EU
Tuesday, June 27, 2017, 8:03 AM — Zacks
Bristol-Myers Reports Data on Immuno-Oncology Drug Empliciti
Tuesday, June 27, 2017, 8:01 AM — Zacks
AbbVie's HCV Combo Drug Gets Positive CHMP Opinion in EU
Tuesday, June 27, 2017, 7:58 AM — Zacks
Noteworthy Thursday Option Activity: COST, ABBV, AET
Thursday, June 22, 2017, 2:33 PM — Stock Options Channel
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, June 21, 2017, 9:12 AM — ETF Channel
Commit To Purchase AbbVie At $40, Earn 2.5% Using Options
Tuesday, June 20, 2017, 11:34 AM — Stock Options Channel
J&J-AbbVie's Imbruvica Positive in Follow-up Lymphoma Study
Tuesday, June 20, 2017, 9:28 AM — Zacks
Health Care Select Sector SPDR Fund Experiences Big Inflow
Monday, June 19, 2017, 10:55 AM — ETF Channel
AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?
Monday, June 19, 2017, 8:28 AM — Zacks
Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx
Thursday, June 15, 2017, 3:38 PM — Zacks
AbbVie a Top Socially Responsible Dividend Stock With 3.6% Yield (ABBV)
Thursday, June 15, 2017, 7:22 AM — ETF Channel
PowerShares Dynamic Pharmaceuticals Portfolio Experiences Big Outflow
Friday, June 9, 2017, 10:45 AM — ETF Channel
AbbVie (ABBV) Announced Positive Phase III RA Candidate Data
Thursday, June 8, 2017, 8:10 AM — Zacks
Notable ETF Inflow Detected - VOO, BRK.B, V, ABBV
Thursday, June 1, 2017, 10:51 AM — ETF Channel
Novartis Biosimilar Pipeline, 2018 Growth Plans on Track
Wednesday, May 31, 2017, 3:30 PM — Zacks
Biogen's Fampyra Conditional Approval Converted to Standard
Thursday, May 25, 2017, 7:16 AM — Zacks
Notable Thursday Option Activity: ABBV, LB, GPS
Thursday, May 18, 2017, 1:34 PM — Stock Options Channel
SPHD's Holdings Imply 10% Gain Potential
Thursday, May 18, 2017, 9:06 AM — ETF Channel
AbbVie Down on Humira Patent Loss: Is More Damage in Store?
Thursday, May 18, 2017, 7:23 AM — Zacks
Celgene's (CELG) Revlimid Looks Solid on Label Expansion
Tuesday, May 16, 2017, 4:14 PM — Zacks
AbbVie and J&J Present Positive Imbruvica Leukemia Data
Monday, May 15, 2017, 8:30 AM — Zacks
Noteworthy ETF Inflows: DGRO, ABBV, MCD, MDT
Friday, May 12, 2017, 10:50 AM — ETF Channel
Notable Wednesday Option Activity: KORS, ABBV, LNG
Wednesday, May 10, 2017, 3:32 PM — Stock Options Channel
Infinity (INFI) Reports Narrower-than-Expected Loss in Q1
Wednesday, May 10, 2017, 7:58 AM — Zacks
iShares Core Dividend Growth ETF Experiences Big Inflow
Thursday, May 4, 2017, 10:46 AM — ETF Channel
Gilead (GILD) Beats on Q1 Earnings, Revenues Miss Estimates
Wednesday, May 3, 2017, 8:25 AM — Zacks
Drug Stocks Q1 Earnings Slated for May 2: MRK, PFE & GILD
Monday, May 1, 2017, 7:40 AM — Zacks
AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Thursday, April 27, 2017, 2:52 PM — Zacks
AbbVie (ABBV) Beats Earnings and Revenue in Q1
Thursday, April 27, 2017, 7:27 AM — Zacks
5 Fantastic Earnings Charts
Wednesday, April 26, 2017, 2:06 PM — Zacks
UPRO, MDT, MCD, ABBV: Large Outflows Detected at ETF
Wednesday, April 26, 2017, 10:50 AM — ETF Channel
Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY
Wednesday, April 26, 2017, 6:04 AM — Zacks
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
Tuesday, April 25, 2017, 2:00 PM — Zacks
Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong
Tuesday, April 25, 2017, 8:46 AM — Zacks
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Monday, April 24, 2017, 8:06 AM — Zacks
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
Friday, April 21, 2017, 9:25 AM — Zacks
What's in Store for AbbVie (ABBV) this Earnings Season?
Friday, April 21, 2017, 7:57 AM — Zacks
Noteworthy Thursday Option Activity: NRZ, ILMN, ABBV
Thursday, April 20, 2017, 3:29 PM — Stock Options Channel
What's in Store for Biogen (BIIB) this Earnings Season?
Thursday, April 20, 2017, 8:16 AM — Zacks
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Thursday, April 20, 2017, 7:53 AM — Zacks
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, April 19, 2017, 8:31 AM — ETF Channel
Noteworthy ETF Inflows: IUSG, UNH, MA, ABBV
Monday, April 17, 2017, 10:54 AM — ETF Channel
The New #141 Most Shorted S&P 500 Component: WEC Energy Group
Wednesday, April 12, 2017, 2:30 PM — Market News Video
AbbVie (ABBV) Shares Cross 4% Yield Mark
Tuesday, April 11, 2017, 3:07 PM — Dividend Channel
Repros' Proellex Continues to be Under Partial Clinical Hold
Tuesday, April 11, 2017, 8:21 AM — Zacks
Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion
Monday, April 10, 2017, 3:27 PM — Zacks
AbbVie's Elagolix Meets Primary Endpoint in Phase II Study
Monday, April 10, 2017, 8:48 AM — Zacks
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Friday, April 7, 2017, 9:58 AM — Dividend Channel
Noteworthy ETF Outflows: XBI, CLVS, BLUE, ABBV
Thursday, April 6, 2017, 10:47 AM — ETF Channel
AbbVie/J&J's Imbruvica Label Expansion Filing Accepted by FDA
Wednesday, April 5, 2017, 9:17 AM — Zacks
Analysts Predict 10% Gains Ahead For FXH
Wednesday, April 5, 2017, 8:19 AM — ETF Channel
XBI, CLVS, ABBV, BLUE: Large Inflows Detected at ETF
Wednesday, March 29, 2017, 10:53 AM — ETF Channel
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe
Tuesday, March 28, 2017, 9:49 AM — Zacks
The New #141 Most Shorted S&P 500 Component: AbbVie
Monday, March 27, 2017, 2:26 PM — Market News Video
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Friday, March 24, 2017, 9:27 AM — Zacks
Notable ETF Inflow Detected - VV, ORCL, ABBV, USB
Wednesday, March 22, 2017, 12:06 PM — ETF Channel
First Week of ABBV November 17th Options Trading
Tuesday, March 21, 2017, 10:38 AM — Stock Options Channel
5 Dividend Aristocrats Where Analysts See Capital Gains
Monday, March 20, 2017, 9:34 AM — ETF Channel
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
Thursday, March 16, 2017, 8:49 AM — Zacks
Infinity (INFI) Reports Narrower-than-Expected Loss in Q4
Wednesday, March 15, 2017, 9:36 AM — Zacks
Noteworthy ETF Inflows: XLV, AMGN, MDT, ABBV
Monday, March 13, 2017, 10:49 AM — ETF Channel
ABBV Named Top 25 SAFE Dividend Stock Increasing Payments For Decades
Monday, March 13, 2017, 7:38 AM — ETF Channel
AbbVie Now #43 Largest Company, Surpassing McDonald's
Friday, March 10, 2017, 4:36 PM — Market News Video
The New #167 Most Shorted S&P 500 Component: AbbVie
Friday, March 10, 2017, 1:37 PM — Market News Video
Noteworthy Tuesday Option Activity: HUM, ABBV, UAA
Tuesday, March 7, 2017, 3:30 PM — Stock Options Channel
Novartis (NVS) Reports Positive Data on Biosimilar Humira
Tuesday, March 7, 2017, 3:21 PM — Zacks
Inovio (INO): What's in the Cards this Earnings Season?
Monday, March 6, 2017, 8:28 AM — Zacks
BioDelivery (BDSI): What's in Store this Earnings Season?
Monday, March 6, 2017, 8:21 AM — Zacks
XLV, AMGN, MDT, ABBV: ETF Inflow Alert
Friday, March 3, 2017, 11:58 AM — ETF Channel
Pricing to Remain Pharma Headline Risk in 2017
Wednesday, March 1, 2017, 5:43 PM — Zacks
Noteworthy Thursday Option Activity: GRA, BOX, ABBV
Thursday, February 23, 2017, 3:37 PM — Stock Options Channel
Vanguard Large-Cap ETF Experiences Big Outflow
Wednesday, February 22, 2017, 10:52 AM — ETF Channel
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Friday, February 17, 2017, 7:13 AM — Zacks
5 Dividend Aristocrats Where Analysts See Capital Gains
Thursday, February 16, 2017, 8:26 AM — ETF Channel
Gilead (GILD) Announces Data on Combination Therapy for HIV
Tuesday, February 14, 2017, 3:18 PM — Zacks
Vanguard Growth ETF Experiences Big Inflow
Tuesday, February 14, 2017, 10:48 AM — ETF Channel
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Monday, February 13, 2017, 8:19 AM — Zacks
AbbVie Becomes #173 Most Shorted S&P 500 Component, Replacing Newell Brands
Friday, February 10, 2017, 2:01 PM — Market News Video
Why AbbVie is a Top 25 Dividend Giant (ABBV)
Thursday, February 9, 2017, 8:07 AM — ETF Channel
Gilead (GILD) Beats Q4 Earnings & Sales, View Disappoints
Wednesday, February 8, 2017, 9:16 AM — Zacks
The Zacks Analyst Blog Highlights: Apple, Visa and AbbVie
Wednesday, February 8, 2017, 8:30 AM — Zacks
VUG, AMGN, MMM, ABBV: Large Inflows Detected at ETF
Monday, February 6, 2017, 10:55 AM — ETF Channel
Roche (RHHBY) Beats on Earnings in 2016, Misses on Sales
Thursday, February 2, 2017, 9:54 AM — Zacks
AbbVie (ABBV) HCV Regimen Gets Priority Review in Canada
Thursday, February 2, 2017, 5:51 AM — Zacks
Analysts Forecast 15% Upside For The Holdings of XLV
Monday, January 30, 2017, 9:13 AM — ETF Channel
Key Takeaways from AbbVie's Q4 Call: Humira and the Pipeline
Monday, January 30, 2017, 7:21 AM — Zacks
Pfizer (PFE) Gets Positive CHMP Opinion for Arthritis Drug
Monday, January 30, 2017, 6:37 AM — Zacks
Amgen Wins Favorable CHMP Opinion for Humira Biosimilar
Monday, January 30, 2017, 6:34 AM — Zacks
AbbVie (ABBV) Q4 Earnings Meet Estimates, Revenues Lag
Friday, January 27, 2017, 1:42 PM — Zacks
VOO, AMGN, MMM, ABBV: Large Outflows Detected at ETF
Friday, January 27, 2017, 10:48 AM — ETF Channel
AbbVie (ABBV) Reports In-Line Q4 Earnings, Revenues Miss
Friday, January 27, 2017, 8:27 AM — Zacks
Friday's Best Earnings Charts
Thursday, January 26, 2017, 2:57 PM — Zacks
Biogen (BIIB) Q4 Earnings Top Estimates; '17 Sales View Soft
Thursday, January 26, 2017, 8:32 AM — Zacks
AbbVie's HCV Regimen Okayed for Accelerated Assessment
Wednesday, January 25, 2017, 9:28 AM — Zacks
Noteworthy Tuesday Option Activity: ABBV, MU, MGM
Tuesday, January 24, 2017, 3:29 PM — Stock Options Channel
Sunesis Offers Updates on SNS-062 and Qinprezo Programs
Tuesday, January 24, 2017, 3:06 PM — Zacks
Can AbbVie (ABBV) Spring a Surprise This Earnings Season?
Tuesday, January 24, 2017, 3:04 PM — Zacks
Gilead (GILD) HCV Therapy Application Validated in Europe
Monday, January 23, 2017, 4:26 PM — Zacks
Can Q4 Earnings Revitalize Healthcare ETFs?
Monday, January 23, 2017, 10:01 AM — Zacks
What's in Store for Abbott Labs (ABT) This Earnings Season?
Friday, January 20, 2017, 4:53 PM — Zacks
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
Friday, January 20, 2017, 1:52 PM — Zacks
4 Drug Stocks Poised to Surprise this Earnings Season
Friday, January 20, 2017, 1:41 PM — Zacks
Abbvie (ABBV) Imbruvica Approved in Lymphoma Indication
Friday, January 20, 2017, 7:14 AM — Zacks
4 Best Marijuana Stocks to Play the Green Rush
Thursday, January 19, 2017, 2:47 PM — Zacks
Noteworthy ETF Inflows: VUG, AMGN, MMM, ABBV
Thursday, January 19, 2017, 10:51 AM — ETF Channel
McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?
Thursday, January 19, 2017, 9:17 AM — Zacks
Allergan's Uterine Fibroids Candidate Positive in Phase III
Wednesday, January 18, 2017, 3:22 PM — Zacks
Coherus Offers Positive Phase III Data on Humira Biosimilar
Friday, January 13, 2017, 8:55 AM — Zacks
AT&T Becomes #132 Most Shorted S&P 500 Component, Replacing AbbVie
Thursday, January 12, 2017, 2:30 PM — Market News Video
Trump Attacks Biotech & Pharma: ETFs Bleed
Thursday, January 12, 2017, 9:08 AM — Zacks
Notable Wednesday Option Activity: ABBV, TSLA, CRM
Wednesday, January 11, 2017, 3:32 PM — Stock Options Channel
XLV, UNH, ABBV, MDT: Large Inflows Detected at ETF
Tuesday, January 10, 2017, 10:50 AM — ETF Channel
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Monday, January 9, 2017, 10:39 AM — Dividend Channel
Pfizer's Humira Biosimilar Meets Primary Endpoint in Study
Friday, January 6, 2017, 7:21 AM — Zacks
Notable Wednesday Option Activity: CHTR, GPS, ABBV
Wednesday, January 4, 2017, 2:27 PM — Stock Options Channel
Agree To Buy AbbVie At $30, Earn 4.1% Using Options
Tuesday, January 3, 2017, 11:51 AM — Stock Options Channel
How The Parts Add Up: IVW Headed For $135
Thursday, December 29, 2016, 10:21 AM — ETF Channel
The New #132 Most Shorted S&P 500 Component: AbbVie
Wednesday, December 28, 2016, 1:49 PM — Market News Video
Noteworthy ETF Inflows: XLV, UNH, ABBV, AGN
Friday, December 23, 2016, 10:53 AM — ETF Channel
Roche (RHHBY) Hemophilia A Drug Positive in Phase III
Friday, December 23, 2016, 7:25 AM — Zacks
AbbVie Breaks Below 200-Day Moving Average - Notable for ABBV
Wednesday, December 21, 2016, 4:50 PM — Dividend Channel
AbbVie (ABBV) Submits NDA for Next-Gen HCV Combo in US
Tuesday, December 20, 2016, 8:40 AM — Zacks
J&J Files sBLA for Plaque Psoriasis in Adolescent Patients
Monday, December 19, 2016, 9:30 AM — Zacks
5 Dividend Aristocrats Where Analysts See Capital Gains
Friday, December 16, 2016, 9:07 AM — ETF Channel
Roche (RHHBY) to Terminate Pacifica Bioscience Agreement
Friday, December 16, 2016, 7:17 AM — Zacks
Gilead to Pay Merck $2.5B in HCV Patent Dispute, Stock Falls
Friday, December 16, 2016, 6:57 AM — Zacks
ABBV Named A Top Socially Responsible Dividend Stock
Thursday, December 15, 2016, 7:22 AM — ETF Channel
XLV, AMGN, ABBV, GILD: ETF Outflow Alert
Wednesday, December 14, 2016, 10:47 AM — ETF Channel
Roche/AbbVie's Leukemia Drug Venclyxto Gains EU Approval
Monday, December 12, 2016, 8:54 AM — Zacks
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Tuesday, December 6, 2016, 9:37 AM — Zacks
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Monday, December 5, 2016, 8:36 AM — Zacks
Notable ETF Inflow Detected - IUSG, GOOG, ABBV, BMY
Thursday, December 1, 2016, 10:48 AM — ETF Channel
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Thursday, December 1, 2016, 9:21 AM — Zacks
Momenta/Shire's Humira Biosimilar Meets Study Objective
Wednesday, November 30, 2016, 8:58 AM — Zacks
We Did The Math MGK Can Go To $98
Monday, November 28, 2016, 9:04 AM — ETF Channel
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Wednesday, November 23, 2016, 7:24 AM — Zacks
J&J (JNJ) Files for Psoriasis Candidate Guselkumab in U.S.
Friday, November 18, 2016, 3:42 PM — Zacks
Notable ETF Inflow Detected - XLV, AMGN, ABBV, GILD
Friday, November 18, 2016, 10:51 AM — ETF Channel
ABBV is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

BDSI News
CYH News
USPH News
THRX News
IPCM News
HALO News
NKTR News
SPPI News
EXEL News
HSP News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AbbVie News | www.RediNews.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.